ZYUS Life Sciences Corporation (V:ZYUS) — Market Cap & Net Worth
Market Cap & Net Worth: ZYUS Life Sciences Corporation (ZYUS)
ZYUS Life Sciences Corporation (V:ZYUS) has a market capitalization of $33.60 Million (CA$46.44 Million) as of April 21, 2026. Listed on the V stock exchange, this Canada-based company holds position #26006 globally and #792 in its home market, demonstrating a 3.57% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ZYUS Life Sciences Corporation's stock price CA$0.58 by its total outstanding shares 80071544 (80.07 Million).
ZYUS Life Sciences Corporation Market Cap History: 2015 to 2026
ZYUS Life Sciences Corporation's market capitalization history from 2015 to 2026. Data shows change from $89.78 Million to $33.60 Million (-8.36% CAGR).
ZYUS Life Sciences Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ZYUS Life Sciences Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
113.20x
ZYUS Life Sciences Corporation's market cap is 113.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $67.19 Million | $207.00K | -$23.45 Million | 324.59x | N/A |
| 2022 | $49.23 Million | $298.00K | -$24.66 Million | 165.22x | N/A |
| 2023 | $52.13 Million | $351.00K | -$42.59 Million | 148.52x | N/A |
| 2024 | $54.45 Million | $481.00K | -$33.80 Million | 113.20x | N/A |
Competitor Companies of ZYUS by Market Capitalization
Companies near ZYUS Life Sciences Corporation in the global market cap rankings as of April 21, 2026.
Key companies related to ZYUS Life Sciences Corporation by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #429 globally with a market cap of $53.93 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #442 globally with a market cap of $52.58 Billion USD ( CN¥359.33 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #516 globally with a market cap of $45.88 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #545 globally with a market cap of $43.42 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #429 | Zoetis Inc | NYSE:ZTS | $53.93 Billion | $122.38 |
| #442 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $52.58 Billion | CN¥56.33 |
| #516 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $39.95 |
| #545 | Haleon plc | NYSE:HLN | $43.42 Billion | $9.75 |
ZYUS Life Sciences Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, ZYUS Life Sciences Corporation's market cap moved from $89.78 Million to $ 33.60 Million, with a yearly change of -8.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$33.60 Million | -17.14% |
| 2025 | CA$40.55 Million | -25.53% |
| 2024 | CA$54.45 Million | +4.44% |
| 2023 | CA$52.13 Million | +5.88% |
| 2022 | CA$49.23 Million | -26.72% |
| 2021 | CA$67.19 Million | -35.56% |
| 2020 | CA$104.26 Million | +50.00% |
| 2019 | CA$69.51 Million | -17.24% |
| 2018 | CA$83.99 Million | 0.00% |
| 2017 | CA$83.99 Million | 0.00% |
| 2016 | CA$83.99 Million | -6.45% |
| 2015 | CA$89.78 Million | -- |
End of Day Market Cap According to Different Sources
On Apr 20th, 2026 the market cap of ZYUS Life Sciences Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $33.60 Million USD |
| MoneyControl | $33.60 Million USD |
| MarketWatch | $33.60 Million USD |
| marketcap.company | $33.60 Million USD |
| Reuters | $33.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ZYUS Life Sciences Corporation
ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2 clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries,… Read more